NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Olive Diagnostics

Olive Diagnostics

Private
JerusalemHealthcare & Life Scienceshttps://www.olivesensing.com/

Last Round

Strategic

Mar 9, 2023

Total Funding Raised

$13.1M

Company Overview

Olive Diagnostics is a healthtech company that has developed a passive, non-invasive urinalysis sensor designed for real-time health monitoring and early disease detection.

Sector

Healthcare & Life Sciences

Verticals

Health IoT, Medical Devices, Sensors, Healthcare Analytics, IoT Hardware

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

urinalysis sensorsmart toilethealth IoTremote patient monitoringIoMTgeriatric care technologypassive health monitoringHardware-as-a-ServiceHaaSclinical analyticsnon-invasive diagnosticsdigital healthchronic disease managementambient sensingtelemedicine hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Olive Diagnostics Comparables

Compare Olive Diagnostics with similar companies based on industry and business-model similarity.

Olive Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Starling Medical
89%
Toi Labs
86%
Medipee GmbH
84%

Olive Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMar 9, 2023
AcceleratorJan 16, 2023
SeedSep 4, 2022
SeedFeb 1, 2022

Key People

Founding team and executive leadership

Guy Goldman

Chief Executive Officer

Executive Team

Olive Diagnostics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2022

    $5.8M raised from Amgen Ventures and eHealth Ventures.

Olive Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Olive Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Olive Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersJerusalem
Employee Range18
Year Founded2019
Last FundingMar 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.